1 study found for:    10959836 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
Conditions: Lymphomas;   Solid Tumors
Interventions: Drug: TRC 102;   Drug: Temozolomide

Indicates status has not been verified in more than two years